Chinese medicinal preparation for treating pyelonephritis
A traditional Chinese medicine preparation and a technology for pyelonephritis are applied in the field of traditional Chinese medicine preparations for the treatment of pyelonephritis, which can solve the problems of few people with exact curative effect, and achieve the effects of low treatment cost, no toxic and side effects, and obvious curative effect.
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- Publication Date
- 2011-01-12
- Estimated Expiration
- Not applicable · inactive patent
Abstract
Description
technical field
[0001] The invention relates to a traditional Chinese medicine preparation for treating pyelonephritis. Background technique
[0002] Pyelonephritis (pyelonephritis) refers to the inflammation of the kidney, mostly caused by bacterial infection, usually accompanied by inflammation of the lower urinary tract, clinically difficult to strictly distinguish. According to the clinical course and disease, pyelonephritis can be divided into acute and chronic two phases, and chronic pyelonephritis is the fruit cause of chronic renal insufficiency.
[0003] Traditional Chinese medicine treats pyelonephritis, mainly by clearing away heat and detoxification, promoting dampness and dredging stranguria, supplemented by tonifying the kidney and strengthening the foundation, promoting blood circulation and removing blood stasis, strengthening the body and eliminating pathogenic factors, and improving the body's immunity to treat the disease. Although there are many prescrip...
Examples
Embodiment Construction
[0009] A kind of traditional Chinese medicine preparation for treating pyelonephritis according to the present invention, the selected raw materials and their weight components are respectively: 30 parts of Rehmannia glutinosa, 30 parts of Rehmannia glutinosa, 30 parts of talc, 30 parts of forsythia, 30 parts of Desmodium, 30 parts of Qianzi, 15 parts of Cortex Dendrobium, 15 parts of Dendrobium, 15 parts of Qumai, 15 parts of Rhizome, 15 parts of Dajiu; its preparations include all dosage forms that are clinically acceptable and suitable for internal use.